Status:
COMPLETED
Safety, Immunogenicity and Compatibility With DTP of a Typhoid Fever Vaccine in Infants
Lead Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
Typhoid Fever
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the safety, immunogenicity, and compatibility of our Vi-rEPA conjugate administered to infants with their routine vaccinations. We propose to recruit 300 full...
Detailed Description
Typhoid fever remains common, serious, and difficult-to-treat throughout the world including Vietnam. Limitations of the three licensed typhoid vaccines have prevented their use for routine vaccinatio...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Healthy full-term newborns.
- Birth weights of \>=2500 grams.
- Exclusion criteria:
- Newborns without maternal and cord blood samples
- Newborns born to mothers with serious medical problems.
Exclusion
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
301 Patients enrolled
Trial Details
Trial ID
NCT00342628
Start Date
July 1 2006
End Date
January 1 2011
Last Update
June 27 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thanh Thuy District Health Center
Việt Trì, Phu Tho, Vietnam